Drugs with this side effect
- 1,25(OH)2D3
- 17-hydroxyprogesterone: 4.6% - 5.8%
- 18F-flutemetamol: 1%
- 2-hydroxysuccinaldehyde: 35% - 56%
- 4-AP: 7%
- 4-PBA: common
- 4-methylpyrazole: 11%
- 5-ASA: postmarketing, rare, 1.3% - 47%
- 5-FU: 10%
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 16% - 42.2%
- 5-azacytidine: very common, 0% - 70.5%
- 5-fluorocytosine
- 6-mercaptopurine
- 6-thioguanine
- 68Ga
- 8-MOP: postmarketing
- A77 1726: 13.7% - 14%
- ACTH(1-39: postmarketing
- ALX 111
- AMD3100: very common, 0% - 34%
- APAs
- Abarelix: 9.88%
- Anidulafungin: 0.997% - 24.4%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 8.18% - 21.7%
- BPTI
- Benicar-HCT: 1% - 2%
- Bivalirudin: postmarketing, 0.1% - 16.1%
- Buscopan
- CAS 1405-87-4
- CAS 76095-16-4: 1.3% - 1.4%
- CAS 76420-72-9
- CGP 19835A: very common, 57%
- Cancidas: 0% - 21.3%
- Cantril
- Carfilzomib: 0% - 44.9%
- Colimycin M
- D-penicillamine
- DFMO: 0.5% - 1%
- Depreotide
- Diane-35
- EACA
- EDTA
- Enfuvirtide: 20.1% - 23.7%
- Eptifibatide: 1%
- Estrofem
- FAMP: 31% - 36%
- FK463: 2.8% - 69.8%
- FP-CIT: uncommon
- FdUrd
- Fe(III: postmarketing, 1.2% - 14.7%
- Forteo: 8.5%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 19% - 32%
- Glat copolymer
- Goserelin: 2% - 14%
- HMDP
- Histrelin
- Hoe 140
- Humalog: 6.17% - 15.1%
- ICI 182,780: postmarketing, 9.7% - 26%
- Implanon: 6.4%
- Insulin: 0.481% - 2.31%
- K779: 3% - 66%
- Kaluril
- L-Dmp: 1.9% - 3.2%
- L-threo-DOPS: 1.53% - 8.77%
- LMWH: 1% - 3%
- LY146032: postmarketing, common, 1.7% - 19.8%
- Leuprorelin: postmarketing, 5% - 17%
- LiOH
- Lisinopril: postmarketing, uncommon, 1.9% - 4.9%
- Lu AA21004: 21% - 32%
- Lutalyse
- Lyxumia: 3.1%
- MK-462
- Madopar
- Meropenem anhydrous: 7.8%
- Mersyndol
- Metrodin: postmarketing, common, 0% - 13.6%
- MnDPDP
- N-acetylcysteine
- N-methylscopolamine
- NSC 352122
- Nafarelin
- NovoLog: 5% - 7%
- NuvaRing
- Nuvocid: 9.94% - 10.5%
- Octreotide: very common, 8.7% - 29.8%
- Oestrogen: uncommon, 0.437% - 11%
- Optison: uncommon, 1%
- Org 37462: uncommon, 0.5%
- PCI-32765: 0% - 26%
- PGE1: 1% - 14%
- PGE2
- Photofrin: 1.45% - 63.6%
- Photofrin II: very common, 11%
- Promacta: 11.9%
- Protirelin
- Refludan
- Revasc: 0.676% - 6.39%
- Romidepsin: 2.29% - 85.5%
- S-benzoylmercaptoacetyltriglycine
- SOM230: 46.3% - 57.5%
- SU5416
- Sativex
- Saxagliptin
- Signifor: 46.3% - 57.5%
- SonoVue
- Stalevo 50
- Supremon: 6.55% - 8.26%
- Symlin
- T-A2-3
- TMC207: 38%
- TMC435: 17% - 22.2%
- TR-700: 8%
- Terlipressin: postmarketing
- Timentin
- TlCl
- Triphasil
- Triptorelin: 2.9%
- Trisequens
- UDCA: postmarketing, 8.3% - 17.4%
- VACV: postmarketing, common, 1% - 23%
- Vancocine: postmarketing, 1% - 17%
- Vitrum
- Zyprexa Relprevv
- abacavir: common, 1.94% - 47%
- abacavir-lamivudine: common
- acamprosate: infrequent, common, 3% - 4%
- acarbose
- acebutolol: 0% - 6%
- acenocoumarol
- acetaminophen: postmarketing, 1.05% - 10%
- acetazolamide
- acetohydroxamic acid
- acipimox
- acitretin: postmarketing, 1-10%
- actinomycin D
- acyclovir: common, 2.4% - 8%
- adefovir: 5%
- adefovir dipivoxil: postmarketing, common, 5%
- adenosine: postmarketing, 3%
- afatinib: 0% - 25%
- agomelatine
- albendazole: 3.7% - 6.2%
- alendronate: postmarketing, 0% - 3.6%
- alfentanil: 17% - 28%
- alfuzosin: common, 1.06%
- aliskiren
- allopurinol: 1.3%
- almotriptan: 1% - 3%
- alosetron: 6%
- alpha-methyl-p-tyrosine
- alprazolam: 1.7% - 31.8%
- amantadine: uncommon, common
- ambrisentan: postmarketing, 3.85% - 4.48%
- amifostine
- amikacin
- amiloride
- aminoglutethimide
- aminophylline
- amiodarone: 3.56% - 4.21%
- amisulpride: common, 2%
- amitriptyline
- amlexanox: 0% - 1.66%
- amlodipine: 2.9%
- amlodipine besylate: 2.9%
- amobarbital
- amoxapine
- amoxicillin: common, 0.654% - 1.32%
- amphetamine
- amphotericin B: 0% - 39.7%
- ampicillin
- amprenavir: very common, 4% - 7%
- amsacrine
- anagrelide: 15% - 17.1%
- anastrozole: 0.7% - 20.7%
- anthracycline: 3% - 51%
- apixaban: common, 2.58% - 2.69%
- apomorphine: 30%
- apraclonidine: postmarketing
- apremilast: 1.8% - 8.92%
- aprepitant: 7.1% - 12.7%
- argatroban: 0% - 11.5%
- argenine vasopressin
- arginine
- aripiprazole: common, 8% - 16%
- arsenic
- arsenic trioxide
- articaine
- asenapine: 2.55% - 3.36%
- aspirin
- atazanavir: postmarketing, common, 2% - 24%
- atenolol: 3% - 4%
- atomoxetine: very common, 7% - 26%
- atorvastatin: 0.4% - 4%
- atosiban: 14%
- atovaquone: 0.6% - 37%
- atropine
- auranofin
- avanafil
- axitinib: 1% - 32%
- azathioprine
- azelastine: postmarketing, 2.8%
- azilsartan: postmarketing
- azilsartan medoxomil
- azithromycin: 3% - 32.6%
- aztreonam
- baclofen: uncommon, common, very common, 1.4% - 10.5%
- balsalazide: 0% - 8.57%
- barium
- barium sulfate
- beclomethasone: 1% - 5%
- beclomethasone dipropionate
- beclomethasone monopropionate: 1% - 5%
- belinostat: 1% - 42%
- benazepril: 1.3%
- benazeprilat: 1.3%
- bendamustine: 0.654% - 75%
- bendrofluazide
- benzathine penicillin
- benzonatate
- benzphetamine
- benztropine
- benzydamine
- bepridil: 6.98% - 26.1%
- betahistine: common
- betaine: postmarketing, uncommon
- betaxolol: postmarketing, 1.2% - 5.8%
- bethanechol
- bexarotene: 7.55% - 16%
- bezafibrate
- bicalutamide: postmarketing, common, 11% - 14%
- bicarbonate
- bile salt
- bimatoprost: postmarketing
- bisacodyl
- bisoprolol: postmarketing, common, 1.5% - 2.2%
- bleomycin hydrochloride
- boceprevir: very common, 38% - 42%
- bortezomib: 0% - 64%
- bosentan: common
- bosutinib: 42.1% - 46%
- bretylium
- brimonidine: postmarketing
- brinzolamide: postmarketing
- bromazepam: postmarketing, 1%
- bromcresol green: 0% - 7%
- bromhexine
- bromocriptine: postmarketing, common, 7% - 49%
- budesonide: 1.8% - 13.1%
- bumetanide: 0.6%
- bupivacaine: 2.11% - 40.2%
- buprenorphine: 6% - 23%
- bupropion: 0.8% - 22.9%
- buspirone: 2% - 8%
- busulfan: 98%
- butabarbital
- butorphanol
- cabazitaxel: 1% - 2%
- cabergoline: 16.4% - 43.3%
- cabozantinib: 0% - 43%
- calcium: 3.59% - 6.12%
- calcium acetate
- canagliflozin: common, 2.2% - 2.3%
- candesartan
- candesartan cilexetil: 1.1% - 2.2%
- capecitabine: 1% - 53%
- capsaicin: uncommon, 2% - 5%
- captopril
- carbamazepine: postmarketing, common, very common, 10% - 29%
- carbenicillin
- carbidopa: 5.5% - 5.7%
- carbimazole
- carbinoxamine
- carboplatin: 15% - 92%
- carboprost
- carisoprodol: postmarketing
- carnitine: 5% - 12%
- carteolol
- carvedilol: 2% - 9%
- cefaclor: 2.5%
- cefadroxil
- cefazolin: postmarketing
- cefdinir
- cefditoren
- cefepime: 2%
- cefixime: 7% - 9%
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil: 2.3% - 3.5%
- ceftaroline: 4%
- ceftazidime: uncommon
- ceftizoxime
- ceftobiprole: 0.5% - 9.1%
- ceftriaxone
- cefuroxime
- cefuroxime axetil: 2.6%
- celecoxib: 3.4% - 11%
- celiprolol
- cephalexin
- cephem
- cerivastatin: 2.4%
- cetirizine: postmarketing, 1.3% - 4.2%
- cetrorelix: 0% - 2%
- cevimeline: 13.8%
- chlorambucil
- chloramphenicol
- chlordiazepoxide
- chloride
- chloroprocaine
- chloroquine
- chlorpheniramine
- chlorpropamide
- chlorthalidone: rare
- choline theophyllinate
- chromium
- ciclesonide: 0.2%
- cidofovir: postmarketing, very common, 7.41% - 68.7%
- cilazapril: postmarketing, 1.3% - 2.9%
- cilostazol: 6% - 7%
- cimetidine: common
- cinacalcet: very common, 31% - 65.5%
- cinoxacin
- ciprofloxacin: uncommon, common, 1.3% - 5.2%
- cisplatin
- citalopram: 2% - 21.4%
- citric acid: postmarketing
- cladribine: very common, 5-28% - 28%
- clarithromycin: postmarketing, uncommon, common, 1% - 5%
- clemastine
- clevidipine: postmarketing, 4.8% - 21.3%
- clindamycin: postmarketing, 2%
- clindamycin phosphate
- clobazam: 1.3%
- clobetasol: postmarketing
- clodronate
- clofarabine: very common
- clofazimine
- clomiphene citrate
- clomipramine: common, frequent, very common, 9% - 33%
- clonazepam
- clonidine: 5% - 13.2%
- clopidogrel: postmarketing, uncommon
- clotrimazole
- clozapine: 3% - 17%
- cobicistat: very common
- codeine
- colchicine: postmarketing, 4.05% - 17.3%
- colesevelam: 2.56% - 4.21%
- colestimide: common
- colestipol
- colestyramine: common
- conivaptan: 3.3%
- conjugated estrogens: postmarketing
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- crizotinib: 1% - 55%
- cyanocobalamin
- cyclobenzaprine: 3% - 8%
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone acetate: very rare, common
- cysteamine: very common, 7% - 16%
- cytarabine: 0% - 53.6%
- d-telaprevir: common, 28%
- dabigatran
- dabigatran etexilate
- dabrafenib: very common, 0% - 50.8%
- dacarbazine
- dalbavancin: 5.5% - 6.37%
- dalteparin: 1.73% - 1.91%
- danazol: 2%
- dantrolene: 9.68% - 10%
- dapagliflozin: 0.2% - 2.8%
- dapsone
- darifenacin: 1.5% - 4.1%
- darunavir: 4% - 25%
- dasatinib: 0% - 24%
- deferasirox: common, 1.54% - 25.7%
- deferiprone
- deferoxamine: common
- degarelix
- delamanid: 38.3%
- delavirdine
- demeclocycline
- demethyl
- deprenyl: 10% - 11%
- desflurane: 1% - 23%
- desipramine
- desloratadine
- desmopressin: 0% - 7%
- desogestrel
- desvenlafaxine: 4% - 41%
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing, common, 3% - 11%
- dexrazoxane: 51% - 82%
- dextran
- dextromethorphan: common
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: postmarketing, common, 0% - 27%
- dicloxacillin: common
- dicyclomine: postmarketing, 14%
- didanosine
- diethylenetriaminepentaacetic acid
- diethylpropion
- diflunisal
- digoxin: 3.25% - 4%
- dihydrocodeine: common
- dihydroergotamine: 10%
- diltiazem: 1.27% - 5%
- dimercaprol
- dimercaptosuccinic acid
- diphenhydramine
- dipyridamole: 4.6%
- disopyramide
- dobutamine
- docetaxel: 1% - 87.2%
- dofetilide: 5%
- dolutegravir: 1% - 15%
- domperidone
- donepezil: 0% - 19%
- dopamine
- doripenem: common, 0.1% - 12%
- dorzolamide
- dothiepin
- doxapram
- doxazosin: 1.2% - 3.9%
- doxepin: 2%
- doxercalciferol: 21.3%
- doxorubicin: postmarketing, common, very common, 0% - 92.4%
- doxycycline: postmarketing, 0.5% - 13.4%
- doxycycline calcium
- doxycycline hyclate: 7.98%
- dronedarone: 5%
- drospirenone (DRSP
- duloxetine: 9% - 30%
- dyphylline
- ecallantide: 5% - 13%
- edrophonium
- efavirenz: common, 0% - 25%
- eletriptan: 4% - 8%
- eliglustat: 0% - 12.3%
- eltrombopag: 4% - 33%
- elvitegravir: common, 4%
- empagliflozin: 1.1% - 2.3%
- emtricitabine: postmarketing, very common, 7% - 10%
- enflurane
- entacapone: very common, 11% - 14%
- entecavir: uncommon, common, 1% - 3%
- ephedrine
- epinephrine
- eplerenone: common
- eprosartan
- ergonovine
- ergotamine
- eribulin: 1% - 35.1%
- erlotinib: 0% - 33%
- ertapenem: 0% - 8.5%
- erythromycin
- erythromycin lactobionate
- erythromycin stearate
- eslicarbazepine
- eslicarbazepine acetate
- esmolol: 6%
- esomeprazole magnesium: 2%
- estazolam: 4%
- estradiol: postmarketing, common, 0% - 6.74%
- estradiol cypionate
- estradiol valerate
- estramustine: 8% - 15%
- estramustine phosphate
- estriol
- estrone
- ethacrynic acid
- ethambutol
- ethionamide
- ethosuximide
- ethotoin
- etidronate: postmarketing
- etodolac
- etoposide: 31 to 43 - 37%
- etoposide phosphate
- etoricoxib
- etravirine: 4.7% - 13.9%
- everolimus: common, very common, 0% - 32%
- exemestane: very common, 5% - 18%
- exenatide: postmarketing, rare, 1.3% - 44%
- ezetimibe: postmarketing
- famciclovir: postmarketing, rare, common, 1.5% - 12.5%
- famotidine: 2%
- febuxostat: 0.8% - 1.3%
- felbamate: 1.4% - 34.2%
- felodipine
- fenofibrate: postmarketing, common, 0.8% - 5.52%
- fenofibric acid: 2.3% - 5.52%
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 45%
- ferumoxytol: postmarketing, 3.1% - 7.5%
- fesoterodine: 0.7% - 1.9%
- fexofenadine: 0.8% - 3.1%
- fidaxomicin: 2.7% - 11.3%
- flavoxate
- flecainide: 4.8% - 8.9%
- florbetapir: uncommon, 0.7%
- flucloxacillin
- fluconazole: postmarketing, 0.7% - 7%
- fludarabine: 1% - 36%
- flumazenil
- flunisolide
- fluocinolone acetonide
- fluorescein: postmarketing, very common
- fluoxetine: infrequent, frequent, very common, 9% - 29.7%
- fluoxymesterone
- fluphenazine
- fluphenazine decanoate
- flurazepam
- flurbiprofen
- flutamide: 9%
- fluticasone: 1% - 8%
- fluticasone furoate: 3.31%
- fluticasone propionate: 2.6% - 5%
- fluvastatin: common, 0.4% - 3.2%
- fluvoxamine: frequent, 6% - 40%
- folate
- fondaparinux: uncommon, 0.3% - 12.2%
- formoterol: very rare
- fosamprenavir: common
- fosaprepitant dimeglumine: 8.5% - 8.6%
- foscarnet
- fosfomycin: 3.4% - 7.2%
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: 0% - 13.6%
- fospropofol
- fotemustine
- frovatriptan
- furosemide
- fusidic acid: 3.7% - 11.9%
- gabapentin: postmarketing, 1.3% - 45%
- gadobenate dimeglumine: postmarketing, 1% - 1.8%
- gadobutrol: 0.5% - 0.9%
- gadodiamide
- gadofosveset
- gadolinium: 0.6% - 3.21%
- gadopentetate: postmarketing, 2.7%
- gadoteridol: 1.43%
- gadoversetamide: 1.74% - 3.21%
- galantamine: 2% - 25%
- ganciclovir: 11% - 30%
- gatifloxacin
- gefitinib: rare, very common, 0% - 23.6%
- gemcitabine: very common, 0% - 87%
- gemeprost
- gemfibrozil: 2.5% - 4.3%
- gemifloxacin: 0.3% - 3.2%
- gentamicin
- glibenclamide
- gliclazide: 0.7% - 1.1%
- glimepiride: 1.1% - 8%
- glipizide
- glucagon
- glucagon hydrochloride
- glutamine: 0% - 31.2%
- glycerol phenylbutyrate: 2.27% - 6.67%
- glycine
- glycopyrrolate
- gold sodium thiomalate
- gonadorelin: common, 0% - 7.24%
- granisetron: 20%
- griseofulvin
- guaifenesin
- guanfacine: postmarketing, 5% - 6%
- guanidinium
- halofantrine: 3.4% - 10%
- haloperidol: very rare, postmarketing
- heparin: postmarketing
- hepatitis B vaccines: common
- hexamethylmelamine
- histamine
- hydralazine: common
- hydrochlorothiazide
- hydrocodone: 7.28% - 9.8%
- hydroflumethiazide
- hydromorphone: 8.96% - 27.6%
- hydroxocobalamin
- hydroxybutyrate: 2.8% - 20%
- hydroxychloroquine
- hydroxyurea: uncommon
- ibandronate: 2% - 5.1%
- ibuprofen: 21% - 57.5%
- ibutilide: 1.9%
- icodextrin: 5% - 7%
- idarubicin: 80% - 82%
- ifosfamide: 58%
- iloperidone: 7% - 10%
- iloprost: 13%
- imatinib: very common, 0.4% - 74%
- imipramine: common
- imiquimod: uncommon, common, 0% - 3.75%
- indacaterol: 2.45%
- indapamide: postmarketing, 2%
- indinavir: 11.7% - 35.3%
- indomethacin: 33% - 34%
- insulin detemir: 2.6% - 7%
- iodide
- iodipamide
- iodixanol: 2.8% - 5.7%
- iohexol
- iopamidol: 1.2% - 7.3%
- iopromide
- iotrolan: 6.7%
- ioversol: 0.6% - 0.8%
- ioxaglate
- ioxilan
- ipratropium bromide: postmarketing, common, 0% - 4.1%
- irbesartan: common, 0.4% - 3.2%
- irbesartan-hydrochlorothiazide: 0.4% - 3.2%
- irinotecan: 2.1% - 86.2%
- iron sucrose: 5.3% - 14.7%
- isocarboxazid
- isoflurane
- isomannide
- isoniazid
- isoproterenol
- isosorbide dinitrate
- isosorbide-5-mononitrate: 1%
- isoxsuprine
- isradipine: 1.8% - 3.1%
- itraconazole: postmarketing, 0% - 15%
- ivabradine
- ivacaftor: 10% - 11.9%
- ivermectin: 1.8% - 6%
- ixabepilone: 40% - 42%
- kanamycin
- ketamine
- ketoconazole
- ketoprofen
- ketorolac: 12%
- ketorolac tromethamine: postmarketing, 0% - 12%
- ketotifen
- labetalol: 1% - 6%
- lacosamide: 0% - 24%
- lactulose
- lamivudine: common, 2% - 46%
- lamotrigine: 0.7% - 25%
- lanreotide
- lansoprazole: 1% - 3.3%
- lanthanum: 11%
- lanthanum carbonate: 11% - 36%
- lapatinib: very common, 0% - 43%
- leflunomide: postmarketing, common, 9% - 19%
- lenalidomide: postmarketing, very common, 0.746% - 29.9%
- lercanidipine: rare, very common
- letrozole: common, 0.117% - 17%
- leucovorin: 6% - 80%
- leuprorelin acetate: 3% - 92.2%
- levetiracetam: 4.2% - 5%
- levobunolol
- levocabastine
- levodopa/carbidopa: 5.5%
- levonorgestrel: postmarketing, 5.5% - 50.5%
- levosimendan
- lidocaine: 2%
- lincomycin
- linezolid: 0% - 6.6%
- liraglutide: postmarketing, 8.5% - 28.4%
- lisdexamfetamine dimesylate: 6% - 7%
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin: 3.5%
- lomitapide
- lomustine
- loperamide: postmarketing, 0.7% - 3.2%
- loratadine
- lorazepam: infrequent, 0.769%
- lorcaserin: 8.26% - 9.38%
- lormetazepam
- losartan: 1.8%
- lovastatin: 1.9% - 2.5%
- loxapine
- lubiprostone: 8% - 29%
- lurasidone: 7% - 14%
- lymecycline
- mTHPC: common
- mannitol: 0% - 1.82%
- maprotiline: 2%
- maraviroc
- mebrofenin
- mecamylamine
- meclofenamate
- medroxyprogesterone: 3.3%
- medroxyprogesterone acetate: 4%
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 0% - 5%
- megestrol acetate
- melatonin
- meloxicam: 0.47% - 7.7%
- melphalan: very common
- memantine: 2.52%
- meperidine
- mephenytoin
- mepivacaine
- meprobamate
- meropenem: 7.8%
- mesna: 33%
- metaproterenol: 3.6% - 18%
- metaxalone
- metformin: very common, 6.5% - 25.5%
- methacholine
- methadone
- methazolamide
- methenamine hippurate
- methenamine silver
- methimazole
- methocarbamol
- methohexital
- methotrexate
- methsuximide
- methyclothiazide
- methyl aminolevulinate
- methyldopa
- methylene blue
- methylene diphosphonate
- methylergometrine
- methylnaltrexone: very common
- methylphenidate: postmarketing, common, very common, 9.66% - 14.3%
- methylprednisolone
- methylprednisolone sodium succinate
- methyltestosterone
- methysergide
- metipranolol
- metoclopramide: postmarketing
- metolazone
- metoprolol: postmarketing, common
- metronidazole: very rare, postmarketing, 2.2% - 18%
- metyrapone: common
- mexiletine: 6.1% - 39.6%
- miconazole: 0.7% - 7.7%
- midazolam: common, 0.504% - 14%
- midodrine: common
- mifepristone
- miglitol: postmarketing
- miglustat: 0% - 22%
- milnacipran: 1.5% - 39%
- minocycline
- minoxidil
- mipomersen: 14%
- mirabegron: 0.4%
- mirtazapine: postmarketing, infrequent, 1.5% - 17%
- misoprostol: 3.2%
- mitomycin C
- mitotane
- mitoxantrone: 0% - 76%
- moclobemide
- modafinil: postmarketing, 1% - 9%
- moexiprilat
- molindone
- mometasone: 1% - 3%
- mometasone furoate: 1% - 3%
- monomethylfumarate: 12%
- monomycin
- montelukast: postmarketing
- morphine: postmarketing, 7% - 9%
- moxifloxacin: 0.8% - 8%
- moxonidine: postmarketing
- mupirocin: 4.9%
- mycophenolate mofetil: 0% - 54.5%
- mycophenolic acid: 19% - 54.5%
- nabilone: postmarketing, 0% - 5%
- nabumetone: 9%
- nadolol
- nafcillin
- nalbuphine
- nalidixic acid
- nalmefene: 18%
- naloxone
- naltrexone: postmarketing, 2% - 10%
- nandrolone
- nandrolone decanoate
- naphazoline
- naproxen: postmarketing
- naratriptan: common, 4% - 16%
- nateglinide: common
- nebivolol: 0.2% - 3%
- nedocromil sodium
- nefazodone: 3.5%
- nefopam
- nelarabine: 0% - 41%
- nelfinavir: common, 0% - 7%
- neomycin
- neostigmine
- nepafenac: rare
- nesiritide: 3.32% - 13%
- nevirapine: common, 0.5% - 9%
- niacin: 4% - 11%
- nicardipine: 1.2% - 4.9%
- nicorandil: common
- nicotine: 2.4% - 5%
- nifedipine: 2% - 11%
- nilotinib: 0% - 34%
- nilutamide: 9.8%
- nimodipine: 1.22%
- nisoldipine: 2%
- nitazoxanide: 3% - 3.1%
- nitrazepam
- nitrofurantoin: 8%
- nitrogen mustard
- nitroglycerin: uncommon, very common
- nitroprusside
- nitrous oxide
- nizatidine: 1.2% - 5.4%
- norethisterone
- norfloxacin: 2.6% - 4.2%
- nortriptyline
- nystatin
- o291
- ofatumumab: 0% - 12%
- ofloxacin: 0.3% - 0.6%
- ogen
- olanzapine: postmarketing, infrequent, 0% - 9%
- olmesartan: postmarketing, 0.189% - 2.05%
- olmesartan medoxomil
- olopatadine: postmarketing
- olsalazine: 3% - 5%
- omeprazole: common, 2% - 6.4%
- orlistat: common, 3.6% - 8.1%
- orphenadrine
- oseltamivir: postmarketing, 3.3% - 17%
- oxacillin
- oxaliplatin: very common, 0.3% - 73.7%
- oxaprozin
- oxazepam
- oxcarbazepine: very rare, very common, 1.7% - 29%
- oxprenolol
- oxybutynin: common, 1.9% - 11.6%
- oxycodone: 23% - 50%
- oxymetholone
- oxymorphone: 2.9% - 33.1%
- oxytetracycline
- oxytocin injection: common
- p-aminohippurate
- paclitaxel: postmarketing, very common, 8% - 70%
- paliperidone: 5% - 8%
- palonosetron: postmarketing
- pamidronate: common, 0% - 63.5%
- pantoprazole: postmarketing, uncommon, 1.16% - 13%
- papaverine
- paraldehyde
- parecoxib
- paricalcitol: 5.6% - 12.9%
- paromomycin
- paroxetine: postmarketing, uncommon, common, frequent, very common, 1.9% - 36.3%
- pazopanib: 0% - 56%
- pegaptanib
- pegaptanib sodium
- pemetrexed: 0% - 84%
- penbutolol: 0.8% - 4.3%
- penciclovir: 2.2% - 12.5%
- penicillin
- penicillin V
- pentamidine
- pentazocine
- pentobarbital
- pentosan polysulfate: 3% - 4%
- pentostatin: 22% - 63%
- pentoxifylline: 2.2% - 28.8%
- perampanel: 3% - 8%
- pergolide: infrequent, frequent, 24.3%
- perhexiline
- perindopril
- perindopril erbumine
- permethrin
- phencyclidine
- phendimetrazine
- phenelzine
- phenobarbital
- phentermine
- phentolamine: common
- phenylazo
- phenylbutyric acid
- phenylephrine
- phenylpropanolamine
- phenytoin: 0% - 13.6%
- phosphate: 26% - 37%
- physostigmine
- pilocarpine: 6% - 15%
- pimecrolimus: 0.375% - 6.7%
- pimozide: 0%
- pinaverium bromide: 0.5%
- pindolol: 1% - 5%
- piperacillin: common
- pirbuterol: 1.3% - 2%
- pirfenidone
- piroxicam: 4.8%
- pitavastatin: postmarketing
- pixantrone
- pizotifen
- poly(styrene sulfonate
- polyoxyethylene
- polythiazide
- pomalidomide: 22.3% - 35.5%
- ponatinib: 0% - 32%
- posaconazole: 2% - 29.3%
- potassium: postmarketing
- pralatrexate
- pralidoxime
- pramipexole: very common, 1% - 28%
- prasugrel: 4.3% - 4.6%
- pravastatin: 1.4% - 7.4%
- praziquantel
- prazosin: 5%
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, rare, infrequent, frequent, 2.2% - 11.7%
- prilocaine
- primaquine
- primidone
- probenecid
- procainamide
- procaine
- procaine penicillin
- procarbazine
- progesterone: postmarketing, 0% - 8%
- proguanil
- propafenone: postmarketing, 2% - 16.9%
- propantheline
- propericiazine
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol: postmarketing
- propylthiouracil
- prostacyclin: 16% - 67%
- prostaglandin
- protriptyline
- prucalopride: uncommon, very common
- pyrantel
- pyrazinamide
- pyridostigmine
- pyridoxine
- quetiapine: 2% - 13.3%
- quinapril
- quinaprilat
- quinidine: 3%
- rabeprazole: 1.8% - 4.5%
- radium: 2% - 36%
- raloxifene: 8.3% - 8.8%
- raltegravir: 2.2% - 9.9%
- raltitrexed: 47-54%
- ramelteon: 0.3% - 3%
- ramipril: 0.6% - 3.8%
- ramiprilat: 2%
- ranitidine
- ranolazine: 3.95% - 4.4%
- rapamycin: 25% - 39%
- rasagiline: common, 6% - 12%
- rasburicase: 1.1% - 57.6%
- reboxetine: postmarketing, 10.7%
- regadenoson: postmarketing, common, 6%
- regorafenib
- remifentanil: very common, 0% - 52%
- repaglinide: 2% - 3%
- rescinnamine
- reserpine
- retapamulin: 1.2% - 1.9%
- retigabine: 6% - 9%
- retinoic acid: postmarketing
- ribavirin: very common, 5% - 47%
- rifabutin: 3% - 6%
- rifampicin
- rifapentine
- rifaximin: 5.31% - 14.3%
- rilpivirine: 1% - 3%
- riluzole: 12.2% - 20.5%
- rimantadine: 1.6% - 2.8%
- rimonabant
- riociguat: 14%
- risedronate: rare, 3.6% - 9.8%
- risperidone: frequent, 0% - 16%
- ritonavir: 23.1% - 46.6%
- rivaroxaban
- rivastigmine: very rare, frequent, very common, 1% - 47%
- rizatriptan: 4% - 6%
- rocuronium
- rofecoxib: 5.2% - 7.4%
- roflumilast: 1.6% - 4.71%
- ropinirole: 1.6% - 60%
- ropivacaine: 3.9% - 40.4%
- rosiglitazone
- rosuvastatin: common, 0% - 6.3%
- rotigotine: 18% - 34%
- roxithromycin
- rufinamide: 1% - 12%
- sacrosidase
- salbutamol: postmarketing, 0% - 19.8%
- salicylate
- salmeterol: 3%
- salmon calcitonin acetate: common, very common
- salsalate
- samarium: 32.7%
- saquinavir: very common
- scopolamine: postmarketing
- secobarbital
- sertraline: postmarketing, rare, very common, 1% - 30%
- sevelamer: 3% - 20%
- sevelamer carbonate: 20%
- sevelamer hydrochloride: 4.9% - 20.2%
- sevoflurane
- sibutramine
- sildenafil: postmarketing, uncommon, 7% - 18%
- silodosin
- simvastatin: 0.4% - 10.1%
- sitagliptin: postmarketing
- sitaxsentan: common, 6.71%
- sodium: 26% - 54%
- sodium bicarbonate
- sodium cromoglycate: 0.3% - 1.6%
- sodium ferric gluconate: 9%
- sodium iodide
- sodium iothalamate
- sodium nitroprusside
- sodium tetradecyl sulphate
- sofosbuvir: very common, 13% - 34%
- solifenacin: 1.7% - 3.3%
- sorafenib: postmarketing, 0% - 24%
- sotalol: 1% - 10%
- sparfloxacin: 4.3% - 7.6%
- spectinomycin
- spironolactone
- stavudine: common, 39% - 44%
- stiripentol
- streptomycin: common
- streptozotocin
- strontium ranelate
- sufentanil
- sugammadex
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 19%
- sulindac
- sumatriptan: common, 11% - 14%
- sunitinib: 4%
- tacrolimus: very common, 0% - 47%
- tadalafil: 10% - 11%
- tamoxifen: 1.03% - 26%
- tamsulosin: postmarketing, uncommon, 2.59% - 3.86%
- tapentadol: 21% - 30%
- technetium-99m: 0.0847% - 0.594%
- teduglutide: 27%
- tegaserod: 5% - 8%
- telavancin: very common, 4% - 27%
- telithromycin: 0.4% - 7.9%
- telmisartan: postmarketing, common, 1.1%
- temazepam: 3.1% - 3.8%
- temozolomide: very common, 0.351% - 53.2%
- temsirolimus
- teniposide: 29%
- tenofovir: 7% - 20%
- tenofovir disoproxil fumarate: postmarketing, common, very common, 2.79% - 20%
- tenoxicam: very common
- terazosin: 0.5% - 4.4%
- terbinafine: very common, 0% - 11%
- terbutaline: 1.3% - 11.5%
- terconazole: postmarketing
- tesamorelin: 4.4%
- testolactone
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine: 13%
- tetracaine
- tetracycline
- tetraen
- tetrahydrobiopterin: postmarketing
- tetrofosmin: 2%
- thalidomide: 0% - 28.4%
- theophylline
- thiabendazole
- thiamine
- thiazide
- thioridazine
- thiosulfate
- thiotepa
- thiothixene
- thymidine: 2.2% - 5.31%
- thyroxine
- tiagabine: 11%
- tiaprofenic acid: 5.8% - 8.2%
- ticagrelor: 3.8% - 4.3%
- ticlopidine
- tigecycline: very common, 1% - 29.5%
- tiludronate
- timolol: 0.6% - 8%
- tinidazole: 3.2% - 4.5%
- tiopronin
- tiotropium
- tipranavir: very common, 4.5% - 6.4%
- tirofiban: 1.7%
- tizanidine
- tobramycin: common, 7.5% - 11.2%
- tofacitinib
- tolazamide
- tolbutamide
- tolcapone: 30%
- tolmetin: 11%
- tolvaptan: very common
- topiramate: postmarketing, rare, 0% - 15.1%
- topotecan: very common, 0% - 64%
- torasemide: 1.8%
- toremifene: postmarketing, 14% - 15%
- trabectedin
- tramadol: postmarketing, rare, very common, 13% - 40%
- tramazoline
- trametinib: 0% - 46%
- trandolapril: postmarketing, 0.5% - 1.15%
- trandolaprilat
- tranexamic acid: postmarketing
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- travoprost
- trazodone: postmarketing, 0.99% - 20.8%
- treprostinil: 0.0909% - 30%
- triamcinolone: postmarketing, 2% - 6.3%
- triamcinolone acetonide: postmarketing
- triamterene
- triazolam: 4.6%
- trifluoperazine
- trifluorothymidine
- trihexyphenidyl
- trimethadione
- trimethoprim: common
- trimethoprim-sulfamethoxazole: common
- trimetrexate: 0.917% - 13.5%
- trimipramine
- troglitazone
- tropicamide
- trospium chloride: 1.38%
- trovafloxacin: 4% - 8%
- ulipristal: 12% - 13%
- umeclidinium
- unoprostone: postmarketing
- ustekinumab: common
- v 1784: postmarketing, common, 1% - 23%
- valdecoxib: 7% - 8.7%
- valganciclovir: 3% - 30%
- valproate: 1.7% - 48%
- valrubicin
- valsartan: uncommon, 1.5%
- vandetanib: 1% - 33.3%
- vardenafil: 2%
- varenicline: 16% - 30%
- vasopressin
- vemurafenib: postmarketing, 2% - 43%
- venlafaxine: postmarketing, common, 2% - 58%
- verapamil: 0.9% - 2.7%
- vernakalant: common
- verteporfin: common
- vigabatrin: common, 2% - 10%
- vilazodone: 23%
- vildagliptin: common
- vinblastine
- vincristine: 52%
- vinflunine
- vinorelbine: 0% - 57%
- vismodegib: 0.7% - 34.8%
- vitamin D2
- voriconazole: very common, 1% - 15.7%
- vorinostat
- warfarin
- zafirlukast: 3.1%
- zaleplon: uncommon, 6% - 8%
- zanamivir: 1% - 3%
- ziconotide: 30% - 40%
- zidovudine: rare, very common, 7% - 61%
- zidovudine/lamivudine
- zileuton: 5.03%
- zinc sulfate
- ziprasidone: 4% - 12%
- zoledronic acid: postmarketing, common, very common, 4.5% - 28%
- zolmitriptan: 1% - 9%
- zolpidem: postmarketing, frequent, 0.5% - 7%
- zonisamide: 9%
- zopiclone: 4% - 5%
- zuclopenthixol
|
Drugs with this indication
|
